Aetna Medical Policy Updates – January 2023

Click here to view the Aetna Medical Policy Updates »

January 2023 Aetna Medical Policy Updates:

• Abatacept (Orencia) [Medicare]
• Alzheimer’s Disease: Experimental Tests
• Androgens and Anabolic Steroids
• Antibody Tests for Neurologic Diseases
• Asfotase alfa (Strensiq)
• Autonomic Testing / Sudomotor Tests
• Azacitidine (Vidaza)
• Back Pain – Invasive Procedures
• Benralizumab (Fasenra)
• Bevacizumab for Non-Ocular Indications
• Bone and Tendon Graft Substitutes and Adjuncts
• Bortezomib (Velcade)
• Botulinum Toxin
• Botulinum Toxin [Medicare]
• BRCA Testing, Prophylactic Mastectomy, and Prophylactic Oophorectomy
• Breast Pumps
• Breast Reduction Surgery and Gynecomastia Surgery
• Brentuximab (Adcetris)
• Bupivacaine Liposome (Exparel)
• Burosumab-twza (Crysvita)
• Cardiac Devices and Procedures for Occlusion of the Left Atrial Appendage
• Certolizumab Pegol (Cimzia)
• Chelation Therapy
• Cochlear Implants and Auditory Brainstem Implants
• Crizanlizumab-tmca (Adakveo)
• Cryoanalgesia and Therapeutic Cold
• Decitabine (Dacogen)
• Denosumab (Prolia and Xgeva)
• Denosumab (Prolia and Xgeva) [Medicare]
• Durvalumab (Imfinzi)
• Edaravone (Radicava)
• Electrical Stimulation for Pain
• Erythropoiesis Stimulating Agents
• Erythropoiesis Stimulating Agents [Medicare]
• Fecal Incontinence
• Femoro-Acetabular Surgery for Hip Impingement Syndrome
• Fibroid Treatment
• Gender Affirming Surgery
• Genetic Testing
• Golimumab (Simponi and Simponi Aria) [Medicare]
• Gonadotropin-Releasing Hormone Analogs and Antagonists
• Heating Devices
• Hematopoietic Colony-Stimulating Factors (CSFs) [Medicare]
• Hip Arthroplasty
• Human Fibrinogen Concentrate (RiaSTAP and Fibryga)
• Implantable Hormone Pellets
• Infertility
• Infliximab
• Infliximab [Medicare]
• Ipilimumab (Yervoy)
• Kidney Transplantation
• Knee Arthroplasty
• Luspatercept-aamt (Reblozyl)
• Magnetic Resonance Imaging of the Cardiovascular System – Cardiac MRI
• Myringotomy and Tympanostomy Tube
• Natalizumab (Tysabri) [Medicare]
• Nivolumab (Opdivo)
• Novel Injection Methods
• Obstructive Sleep Apnea in Adults
• Parkinson’s Disease
• Pembrolizumab (Keytruda)
• Pharmacogenetic and Pharmacodynamic Testing
• Pneumococcal Vaccine
• Polymerase Chain Reaction Testing: Selected Indications
• Positron Emission Tomography (PET)
• Pressure Reducing Support Surfaces
• Progestins
• Pulmonary Hypertension Treatments and Selected Indications of Prostanoids
• Recombinant Human Parathyroid Hormone (Natpara)
• Rituximab
• Rituximab [Medicare]
• Shoulder Arthroplasty and Arthrodesis
• Skin and Soft Tissue Substitutes
• Spinal Surgery: Laminectomy and Fusion
• Tocilizumab (Actemra) [Medicare]
• Transrectal Ultrasound
• Transvaginal Ultrasonography
• Trastuzumab (Herceptin and biosimilars), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)
• Trastuzumab (Herceptin and biosimilars), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) [Medicare]
• Tumor Markers
• Urinary Incontinence
• Ustekinumab (Stelara) [Medicare]
• Vascular Endothelial Growth Factor Inhibitors for Ocular Indications
• Vascular Endothelial Growth Factor Inhibitors for Ocular Indications [Medicare]
• Viscosupplementation [Medicare]
• Wrist Arthroplasty

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.